Open access
Sep 2026
Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington’s disease progression
The results indicate and confirm that TNFRSF8 is highly dysregulated in HDGECs and also tracks clinical disease progression, and may be a promising potential target for DMTs.
Helga Maria Grétarsdóttir, Janet L. Cunningham, A. Rasmusson et al.
· Journal of Neurology · 0 citations